Syndicated Solutions

Sales Partnership Propels Vesicare to Market Leader for Astellas

Astellas needed to rapidly ramp up its sales force by 50% to take advantage of a projected $1 billion opportunity.

Quintiles provided a new risk sharing partnership framework through the deployment of highly trained syndicated sales teams.

Download PDF

White Paper

New Voices, New Opportunities: Toward a Patient-Centric Biopharmaceutical Commercialization Model

Biopharmaceutical companies must learn to navigate the increasingly tricky waters of commercializing products by adjusting to the needs of a new set of stakeholders.

Read more